| Company Name: |
Hubei Yangxin Medical Technology Co., Ltd.
|
| Tel: |
15374522761 |
| Email: |
3003392093@yongstandards.com |
| Products Intro: |
Product Name:Pazufloxacin Impurity 22（Pazufloxacin-d4）
CAS:1346602-96-7
Purity:99%+ HPLC Package:10mg;25mg;50mg;100mg
|
| Company Name: |
Jinan blalong chemical co. LTD
|
| Tel: |
2710913286@.com |
| Email: |
1513643261@qq.com |
| Products Intro: |
Product Name:Pazufloxacin Impurity 22 (Pazufloxacin-d4)
CAS:1346602-96-7
Purity:99% HPLC Package:50G;10G;1G;500MG;100MG
|
| Company Name: |
Shenzhen ruikai de biotechnology co., ltd.
|
| Tel: |
0755-61348847 17820674378 |
| Email: |
2682116078@qq.com |
| Products Intro: |
Product Name:Pazufloxacin-d4
CAS:1346602-96-7
Purity:98%HPLC Package:10mg;25mg;50mg;100mg
|
|
| | Pazufloxacin Impurity 22(Pazufloxacin-d4) Basic information |
| | Pazufloxacin Impurity 22(Pazufloxacin-d4) Chemical Properties |
| | Pazufloxacin Impurity 22(Pazufloxacin-d4) Usage And Synthesis |
| Uses | Pazufloxacin-d4 is deuterium labeled Pazufloxacin. | | References | [1] Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. DOI:10.1177/1060028018797110
[2] Fukuoka, Y., et al., In vitro and in vivo antibacterial activities of T-3761, a new quinolone derivative. Antimicrob Agents Chemother, 1993. 37(3): p. 384-92. DOI:10.1128/AAC.37.3.384
[3] Muratani, T., M. Inoue, and S. Mitsuhashi, In vitro activity of T-3761, a new fluoroquinolone. Antimicrob Agents Chemother, 1992. 36(10): p. 2293-303. DOI:10.1128/AAC.36.10.2293 |
| | Pazufloxacin Impurity 22(Pazufloxacin-d4) Preparation Products And Raw materials |
|